Date Initiated by Firm | May 17, 2017 |
Create Date | June 03, 2017 |
Recall Status1 |
Terminated 3 on June 18, 2019 |
Recall Number | Z-2247-2017 |
Recall Event ID |
77352 |
Product Classification |
Injector, vertebroplasty (does not contain cement) - Product Code OAR
|
Product | KYPHON(R) Directional Bone Filler Device, Size: 3, REF F04C, Rx Only, STERILE R. |
Code Information |
All Lots |
Recalling Firm/ Manufacturer |
Medtronic Sofamor Danek USA Inc 1800 Pyramid Pl Memphis TN 38132-1703
|
For Additional Information Contact | Eric Epperson 901-344-1435 |
Manufacturer Reason for Recall | The directional arrow at the proximal end of the instrument may not correctly align with the cutout opening on the distal end of the instrument. Using affected bone void filler may result in the injected cement being placed in a direction unintended by the surgeon. |
FDA Determined Cause 2 | Nonconforming Material/Component |
Action | Medtronic distributed a voluntary removal notice (Attachment I) via FedEx courier service to impacted U.S. consignees on 17 May 2017. Communications to impacted consignees outside the United States are currently ongoing per each geographies local procedures.
The consignees were directed to do the following:
1.) Please locate and remove the impacted product from normal storage locations. Do not use this product.
2.) Complete the enclosed Customer Confirmation Form and return via fax to 763-367-8134, or via e-mail to rs.sdmriskmgt@medtronic.com.
3.) As applicable, contact your Medtronic Sales Representative to coordinate the return and replacement of affected product. |
Quantity in Commerce | 17657 units |
Distribution | worldwide |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|